推荐文献 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial
Management of No-Reflow Phenomenon in the Catheterization Laboratory
Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
稳定性冠心病诊断与治疗指南
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center
Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease
Circadian Cadence and NR1D1 Tune Cardiovascular Disease
Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI

Guideline

2019 Jan 28. pii: S1547-5271(19)30037-2.

JOURNAL：Heart Rhythm.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

January CT, Wann LS, Calkins H et al.

5149

Keywords: acute coronary syndrome; anticoagulants; antiplatelet agents; apixaban; atrial fibrillation; atrial flutter; coronary artery disease; dabigatran; edoxaban; idarucizumab; warfarin;

FULL TEXT PDF